Literature DB >> 12954462

Underpowering in randomized trials reporting a sample size calculation.

Andrew J Vickers1.   

Abstract

OBJECTIVE: The objective of this study was to determine whether standard deviations (SDs) used in sample size calculations are smaller than those found in the resulting study sample, thereby leading to underpowered studies.
METHOD: The predicted SD used in the sample size calculation and the actual SD of the study sample were recorded for randomized trials recently published in one of four major journals.
RESULTS: Sample SD was greater than predicted SD for 80% of endpoints. About one quarter of trials required five times as many patients as specified in the sample size calculation.
CONCLUSION: Trials reporting sample size calculations for continuous endpoints published in the most reputable medical journals are often underpowered. There seems to be insufficient understanding that the SD of a sample of patients is a random variable, associated with imprecision, that cannot easily be extrapolated from one population to another.

Entities:  

Mesh:

Year:  2003        PMID: 12954462     DOI: 10.1016/s0895-4356(03)00141-0

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  26 in total

1.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

Authors:  An-Wen Chan; Karmela Krleza-Jerić; Isabelle Schmid; Douglas G Altman
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

Review 2.  Training and fidelity monitoring of behavioral interventions in multi-site addictions research.

Authors:  John S Baer; Samuel A Ball; Barbara K Campbell; Gloria M Miele; Eugene P Schoener; Kathlene Tracy
Journal:  Drug Alcohol Depend       Date:  2006-10-04       Impact factor: 4.492

3.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

4.  The association between global DNA methylation and telomere length in a longitudinal study of boilermakers.

Authors:  Jason Y Y Wong; Immaculata De Vivo; Xihong Lin; Rachel Grashow; Jennifer Cavallari; David C Christiani
Journal:  Genet Epidemiol       Date:  2014-02-24       Impact factor: 2.135

5.  A Pilot Randomized Controlled Trial of an Integrated In-person and Mobile Phone Delivered Counseling and Text Messaging Intervention to Reduce HIV Transmission Risk among Male Sex Workers in Chennai, India.

Authors:  Matthew J Mimiaga; Beena Thomas; Katie Biello; Blake E Johnson; Soumya Swaminathan; Pandiyaraja Navakodi; S Balaguru; A Dhanalakshmi; Elizabeth F Closson; Sunil Menon; Conall O'Cleirigh; Kenneth H Mayer; Steven A Safren
Journal:  AIDS Behav       Date:  2017-11

Review 6.  Current sample size conventions: flaws, harms, and alternatives.

Authors:  Peter Bacchetti
Journal:  BMC Med       Date:  2010-03-22       Impact factor: 8.775

7.  Evidence at a glance: error matrix approach for overviewing available evidence.

Authors:  Frederik Keus; Jørn Wetterslev; Christian Gluud; Cornelis J H M van Laarhoven
Journal:  BMC Med Res Methodol       Date:  2010-10-01       Impact factor: 4.615

Review 8.  Reporting of sample size calculation in randomised controlled trials: review.

Authors:  Pierre Charles; Bruno Giraudeau; Agnes Dechartres; Gabriel Baron; Philippe Ravaud
Journal:  BMJ       Date:  2009-05-12

9.  Acupuncture for persistent allergic rhinitis: a multi-centre, randomised, controlled trial protocol.

Authors:  Jong-In Kim; Myeong Soo Lee; So-Young Jung; Jun-Yong Choi; Sanghoon Lee; Jeong-Min Ko; Hong Zhao; Jiping Zhao; Ae-Ran Kim; Mi-Suk Shin; Kyung-Won Kang; Hee-Jung Jung; Tae-Hun Kim; Baoyan Liu; Sun-Mi Choi
Journal:  Trials       Date:  2009-07-14       Impact factor: 2.279

10.  Sensory Stimulation of the Foot and Ankle Early Post-stroke: A Pilot and Feasibility Study.

Authors:  Alison M Aries; Valerie M Pomeroy; Julius Sim; Susan Read; Susan M Hunter
Journal:  Front Neurol       Date:  2021-07-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.